First Report of blaCTX-M-15 Extended Spectrum Beta-Lactamase (ESBL) Producing E. Coli Isolated from Cloacal Swabs of Birds in South Eastern Nigeria
DOI:
https://doi.org/10.21276/0kxe0315Keywords:
Birds, Escherichia coli, ESBLs, blaCTX-M-15, Cloacal Swabs, Antimicrobial ResistanceAbstract
Introduction: In this study, we investigated the presence of some beta-lactamases namely SHV, TEM and the most widely spread extended spectrum beta-lactamase (blaCTX-M-15) genes in E. coli isolated from four different bird species including ducks, pigeons, weaverbirds and bats in Ebonyi State, Nigeria.
Methodology: Genes for ESBL production was determined based on PCR amplification of the genes encoding the enzymes including TEM, SHV and CTX-M-15 using specific primers. One hundred and fifty cloacal swabs each from ducks and pigeons and 100 each from weaverbirds and bats were respectively collected using sterile swab sticks. Antibiotic susceptibility test on the isolates was conducted using disc diffusion method while the phenotypic determination of ESBL was carried out using Double Disc Synergy Tests (DDST). Observations: Results from this study showed that E. coli was present in all the 4 bird species investigated. Of the 117 isolates screened for ESBL production, only 3(5.56 %) and 9(16.67 %), respectively were positive from ducks and pigeons while none was positive from bats and weaverbirds. Results of the molecular studies showed that the ESBL producing E. coli from pigeons were negative for SHV genes, positive for TEM and CTX-M-15 while those from ducks did not harbour any of the beta-lactamase and ESBL genes investigated. Conclusion: The detection of similar types of beta-lactamase and ESBL genes (TEM and CTX-M-15) in pigeon samples indicates the possible involvement of some bird species in the spread of multidrug resistant genes across human population. This is the first report of CTX-M-15 ESBL in bird species from Southeast Nigeria.
Downloads
References
Guenther S, Ewers S, Wieler LH. Review: ESBL-producing E. coli in Wildlife, yet another form of Environmental Pollution? Frontiers in Microbiology. 2011;2:246.
Wellington EMH, Boxall ABA, Cross P et al. The Role of the Natural Environment in the Emergence of Antibiotic Resistance in Gram-negative Bacteria. Lancet Infectious Diseases, 2013;13:155–165.
Canton R, Novais A, Valverde A. Prevalence and Spread of Extended- Spectrum beta-Lactamase-Producing Enterobacteriaceae in Europe. Clinical Microbiology and Infection. 2008;14(1):144-153.
Sun HY, Chen SY, Chang SC, Pan SC, Su CP, Chen YC. Community-Onset Escherichia coli and Klebsiella pneumoniae Bacteremia: Influence of Health Care Exposure on Antimicrobial Susceptibility. Diagnostic Microbiology and Infectious Disease. 2006;55(2):135-141.
Kotapati S, Kuti JL, Nightingale CH. Clinical Implications of Extended Spectrum Beta Lactamase (ESBL) Producing Klebsiella species and Escherichia coli on Cefepime Effectiveness. Journal of Infection. 2005;51(3):211-217.
Faith D, Villanueva M, Thelma E. Extended Spectrum β-Lactamase Production among Escherichia coli and Klebsiella spp. Philippines Journal Microbiological Infectious Diseases. 2003;32(3):103-108.
Bradford PA. Extended Spectrum β-Lactamases in the 21st Century: Character¬ization, Epidemiology and Detection of this Important Threat. Clinical Microbiology Reviews. 2001;14:933–951.
Paterson DL, Bonomo RA. Extended-Spectrum ß-Lactamases: a Clinical Update. Clinical Microbiology Review. 2005;18(4):657-686.
Bali EB, Açik L, Sultan N. Phenotypic and Molecular characterization of SHV, TEM, and CTX-M and extended-spectrum β – lactamase produced by Escherichia coli, Acinetobacter baumanii and Klebsiella isolates in Turkish hospital. African Journal of Microbiology Research. 2010;4(8):650-654.
Jacoby GA, Munoz-Price LS. Mechanism of disease: The new β-lactamases. N Engl J Med. 2005;352:380-91.
Poirel L, Potron A, De La Cuesta C, Cleary T, Nordmann P, Munoz-Price LS. Wild Coastline Birds as Reservoirs of Broad-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Miami Beach, Florida. Antimicrobial Agents and Chemotherapy. 2012; 56:2756–2758.
Pitout JD and Laupland KB. Extended-SpectrumBeta-Lactamase-Producing Enterobacteriaceae: an Emerging Public-Health Concern. Lancet Infectious Disease. 2008;8:159–166.
Saha R, Jain S, Kaur I.R. Metallo-beta-lactamase producing Pseudomonas species – a major cause of concern among hospital associated urinary tract infections. Journal of Indian Medical Association. 2010;108(6):344-348.
Nordmann P, Guibert M. Extended Spectrum ß-Lactamases in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 1998;42:128-131.
Bush K and Jacoby GA. Updated Functional Classification of β-Lactamases. Antimicrobial Agents and Chemotherapy. 2010;54:969–976.
Livermore DM, Canton R, Gniadkowski M et al. CTX-M: Changing the Face of ESBLs in Europe. Journal of Antimicrobial Chemotherapy. 2007;59:165–174.
Costa D, Poeta P, Sa´enz Y, et al. Mechanisms of Escherichia coli Isolates Recovered from Wild Animals. Microbial Drug Resistance. 2008;14:1–77.
MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect. 2002;8:715–24.
Dolejska M, Cizek A and Literak I. High Prevalence of Antimicrobial-Resistant Genes and Integrons in Escherichia coli isolates from Black-Headed Gulls in the Czech Republic. Journal of Applied Microbiology. 2007;103:11–19.
Guenther S, Grobbel M, Beutlich J, et al.CTX- M-15-type Extended-Spectrum Beta-Lactamases Producing Escherichia coli from Wild Birds in Germany. environmental Microbiology Reports. 2010a;2:641–645.
Guenther, S., Grobbel, M., Beutlich, J et al. Detection of pandemic B2-O25- ST131 Escherichia coli Harbouring the CTX-M-9 Extended-Spectrum Beta-Lactamase type in a Feralurban Brown Rat (Rattus norvegicus). Journal of Antimicrobial Chemotherapy. 2010b;65:582–584.
Costa D, Poeta P, Sa´enz Y, et al. Mechanisms of Escherichia coli Isolates Recovered from Wild Animals. Microbial Drug Resistance. 2008;14:1–77.
Gilliver M, Bennett M, Begon M, Hazel SM, Hart CA. Enterobacteria: Antibiotic resistance found in rodents. Nature. 1999;401:233-234.
Rahuma N, Ghenghesh KS, Ben AR, Elamaari A. Carriage by the Housefly (Musca domestica) of Multiple Antibiotic-Resistant Bacteria that are Potentially Pathogenic to Humans in Hospital and other Urban Environments in Misurata, Libya. Annals of Tropical Medicine and Parasitology. 2005;99:795–802.
Jones JG, Gardener S, Simon BM, Pickup RW. Antibiotic Resistant Bacteria in Windermere and Two Remote Upland Tarns in the English Lake District. Journal of Applied Bacteriology. 1986;60:443–453.
Pagano A, Nardi G, Bonaccorso C et al. Faecal Bacteria of wild Ruminants and the Alpine Marmot. Veterinary Research Communication. 1985;9:227–232.
Heather KA, Justin D, Helena HW, Karen AC, Julian D, Jo H. Call of the Wild: Antibiotic Resistance Genes in Natural Environments. Nature Reviews Microbiology. 2010;1-9.
Silva N, Igrejas G, Rodrigues P et al. Molecular Characterization of Vancomycin-Resistant Enterococci and Extended-Spectrum β-Lactamase-Containing Escherichia coli Isolates in Wild Birds from the Azores Archipelago. Avian Pathology. 2011;40(5):473-9.
Radhouani H, Pinto L, Coelho C et al. Detection of Escherichia coli Harboring Extended-Spectrum β-Lactamases of the CTX-M Classes in Faecal Samples of Common Buzzards (Buteo buteo). Journal of Antimicrobial Chemotherapy. 2010;65:171-173.
Cheesbrough M. District Laboratory Practice in Tropical Countries, Part two, 2nd edn. Cambridge University Press, UK. 2002;Pp 143-187.
Iroha IR, Oji AE, Esimone CO. Antimicrobial Resistance Pattern of Plasmid-Mediated Extended Spectrum Beta–Lactamase Producing Strains of Escherichia coli. Science Research Essay. 2008;3(6):215-218.
National Committee for Clinical LaboratoryStandards, (NCCLS). NCCLS document M 100-S15. Performance Standards for Antimicrobial Susceptibility Testing. 8th ed. Pennsylvania: NCCLS: Wayne. 2004.
Clinical Laboratory Standard Institute (CLSI). Performance Standard for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI document M100S15. CLSI, Wayne, PA htt://www.fsis.usda.gov. 2005.
National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing. NCCLS Approved Standard M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA, USA. 2000.
Iroha IR, Adikwu MU, Esimone CO, Aibinu I, Amadi ES. Extended Spectrum Beta-Lactamase (ESBL) in Escherichia coli Isolated from a Tertiary Hospital in Enugu State, Nigeria. Pakistan Journal of Medical Sciences. 2009;25(2):279-282.
Pitout JD, Hossain A, Hanson ND. Phenotypic and Molecular Detection of CTX-M- Beta-Lactamases Produced by E. coli and Klebsiella spp. Journal of Clinical Microbiology. 2004;42:5715-5721.
Abreu AG, Marques SG, Monteiro-Neto V, Luz VD, Gonçalves AG. Nosocomial Infection and Characterization of Extended-Spectrum β-lactamases-Producing Enterobacteriaceae in Northeast Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 2011; 44(4):441-446.
Letters to the Editor. Are SHV beta-lactamases universal in Klebsiella pneumoniae? Antimicrobial Agents and Chemotherapy. 2000;44(8):2230.
Paterson DL, Hujer KM, Hujer AM et al. Extended-Spectrum-Lactamases in Klebsiella pneumonia Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type-Lactamases. Antimicrobial Agents and Chemotherapy. 2003;47(11):3554–3560.
Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrobial Agents and Chemotherapy. 2003;47:3724-3732.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
